37
Views
1
CrossRef citations to date
0
Altmetric
Review

Biventricular pacing in heart failure: a review

, &
Pages 97-109 | Published online: 10 Jan 2014

References

  • Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22(17), 1527–1560 (2001).
  • HFSA. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction – pharmacological approaches. J. Card. Fail. 5(4), 357–382 (1999).
  • SOLVD. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N. Engl. J. Med. 325(5), 293–302 (1991).
  • Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341(10), 709–717 (1999).
  • CIBIS-II. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II), a randomised trial. Lancet 353(9146), 9–13 (1999).
  • MERIT-HF. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353(9169), 2001–2007 (1999).
  • Lapointe N, Blais C Jr, Adam A et al. Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat. J. Am. Coll. Cardiol. 39(10), 1692–1698 (2002).
  • Mandi Y, Farkas G, Ocsovszky I, Nagy Z. Inhibition of tumor necrosis factor production and ICAM-1 expression by pentoxifylline: beneficial effects in sepsis syndrome. Res. Exp. Med. (Berl.) 195(5), 297–307 (1995).
  • Grimm W, Glaveris C, Hoffmann J et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: design and first results of the Marburg Cardiomyopathy Study. Pacing Clin. Electrophysiol. 21(11 Pt 2), 2551–2556 (1998).
  • Baldasseroni S, Opasich C, Gorini M et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 out-patients with congestive heart failure: a report from the Italian network on congestive heart failure. Am. Heart J. 143(3), 398–405 (2002).
  • Xiao HB, Roy C, Fujimoto S, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int. J. Cardiol. 53(2), 163–170 (1996).
  • Zimetbaum PJ, Buxton AE, Batsford W et al. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation 110(7), 766–769 (2004).
  • Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. QRS duration and mortality in patients with congestive heart failure. Am. Heart J. 143(6), 1085–1091 (2002).
  • Baldasseroni S, Gentile A, Gorini M et al. Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital. Heart J. 4(9), 607–613 (2003).
  • Das MK, Cheriparambil K, Bedi A et al. Prolonged QRS duration (QRS >/= 170 ms) and left axis deviation in the presence of left bundle branch block: A marker of poor left ventricular systolic function? Am. Heart J. 142(5), 756–759 (2001).
  • Recke SH, Esperer HD, Eberlein U, Gansser R, von der Emde J. Assessment of left ventricular function from the electrocardiogram in left bundle branch block. Int. J. Cardiol. 24(3), 297–304 (1989).
  • Shamim W, Francis DP, Yousufuddin M, Varney S, Pieopli MF, Anker SD et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int. J. Cardiol. 70(2), 171–178 (1999).
  • Xiao HB, Brecker SJ, Gibson DG. Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy. Br. Heart J. 68(4), 403–407 (1992).
  • Kerwin WF, Botvinick EH, O’Connell JW et al. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J. Am. Coll. Cardiol. 35(5), 1221–1227 (2000).
  • Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J. Am. Coll. Cardiol. 33(6), 1735–1742 (1999).
  • Prinzen FW, Augustijn CH, Arts T, Allessie MA, Reneman RS. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am. J. Physiol. 259(2 Pt 2), 300–308 (1990).
  • Wyman BT, Hunter WC, Prinzen FW, McVeigh ER. Mapping propagation of mechanical activation in the paced heart with MRI tagging. Am. J. Physiol. 276(3 Pt 2), 881–891 (1999).
  • Curry CW, Nelson GS, Wyman BT et al. Mechanical dyssynchrony in dilated cardiomyopathy with intraventricular conduction delay as depicted by 3D tagged magnetic resonance imaging. Circulation 101(1), E2 (2000).
  • Park RC, Little WC, O’Rourke RA. Effect of alteration of left ventricular activation sequence on the left ventricular end-systolic pressure-volume relation in closed-chest dogs. Circ. Res. 57(5), 706–717 (1985).
  • Burkhoff D, Oikawa RY, Sagawa K. Influence of pacing site on canine left ventricular contraction. Am. J. Physiol. 251(2 Pt 2), 428–435 (1986).
  • Heyndrickx GR, Vantrimpont PJ, Rousseau MF, Pouleur H. Effects of asynchrony on myocardial relaxation at rest and during exercise in conscious dogs. Am. J. Physiol. 254(5 Pt 2), 817–822 (1988).
  • Xiao HB, Lee CH, Gibson DG. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br. Heart J. 66(6), 443–447 (1991).
  • Erlebacher JA, Barbarash S. Intraventricular conduction delay and functional mitral regurgitation. Am. J. Cardiol. 88(1), A7, 83–86 (2001).
  • Baller D, Wolpers HG, Zipfel J, Bretschneider HJ, Hellige G. Comparison of the effects of right atrial, right ventricular apex and atrioventricular sequential pacing on myocardial oxygen consumption and cardiac efficiency: a laboratory investigation. Pacing Clin. Electrophysiol. 11(4), 394–403 (1988).
  • Owen CH, Esposito DJ, Davis JW, Glower DD. The effects of ventricular pacing on left ventricular geometry, function, myocardial oxygen consumption, and efficiency of contraction in conscious dogs. Pacing Clin. Electrophysiol. 21(7), 1417–1429 (1998).
  • Sarubbi B, Ducceschi V, Santangelo L, Iacono A. Arrhythmias in patients with mechanical ventricular dysfunction and myocardial stretch: role of mechano-electric feedback. Can. J. Cardiol. 14(2), 245–252 (1998).
  • Miura M, Wakayama Y, Sugai Y et al. Effect of transient stretch on intracellular Ca2+ during triggered propagated contractions in intact trabeculae. Can. J. Physiol. Pharmacol. 79(1), 68–72 (2001).
  • Keurs HE, Zhang YM, Davidoff AW, Boyden PA, Wakayama Y, Miura M. Damage induced arrhythmias: mechanisms and implications. Can. J. Physiol. Pharmacol. 79(1), 73–81 (2001).
  • Xiao HB, Brecker SJ, Gibson DG. Differing effects of right ventricular pacing and left bundle branch block on left ventricular function. Br. Heart J. 69(2), 166–173 (1993).
  • Fauchier L, Marie O, Casset-Senon D, Babuty D, Cosnay P, Fauchier JP. Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy: a prognostic study with fourier phase analysis of radionuclide angioscintigraphy. J. Am. Coll. Cardiol. 40(11), 2022–2030 (2002).
  • Kass DA. Predicting cardiac resynchronization response by QRS duration: the long and short of it. J. Am. Coll. Cardiol. 42(12), 2125–2127 (2003).
  • Brecker SJ, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 340(8831), 1308–1312 (1992).
  • Hochleitner M, Hortnagl H, Ng CK, Gschnitzer F, Zechmann W. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am. J. Cardiol. 66(2), 198–202 (1990).
  • Brecker SJ, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 340(8831), 1308–1312 (1992).
  • Nishimura RA, Hayes DL, Holmes DR Jr, Tajik AJ. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. J. Am. Coll. Cardiol. 25(2), 281–288 (1995).
  • Innes D, Leitch JW, Fletcher PJ. VDD pacing at short atrioventricular intervals does not improve cardiac output in patients with dilated heart failure. Pacing Clin. Electrophysiol. 17(5 Pt 1), 959–965 (1994).
  • Gold MR, Feliciano Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J. Am. Coll. Cardiol. 26(4), 967–973 (1995).
  • Linde C, Gadler F, Edner M, Nordlander R, Rosenqvist M, Ryden L. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am. J. Cardiol. 75(14), 919–923 (1995).
  • Blanc JJ, Etienne Y, Gilard M et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 96(10), 3273–3277 (1997).
  • deCock CC, Giudici MC, Twisk JW. Comparison of the haemodynamic effects of right ventricular outflow-tract pacing with right ventricular apex pacing: a quantitative review. Europace 5(3), 275–278 (1997).
  • Twidale N, Manda V, Holliday R et al. Mitral regurgitation after atrioventricular node catheter ablation for atrial fibrillation and heart failure: acute hemodynamic features. Am. Heart J. 138(6 Pt 1), 1166–1175 (1999).
  • Stambler BS, Ellenbogen K, Zhang X et al. Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. J. Cardiovasc. Electrophysiol. 14(11), 1180–1186 (2003).
  • Wilkoff BL, Cook JR, Epstein AE et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288(24), 3115–3123.
  • Cazeau S, Ritter P, Lazarus A et al. Multisite pacing for end stage heart failure: early experience. Pacing Clin. Electrophysiol. 19(11 Pt 2), 1748–1757 (2002).
  • Cazeau S, Ritter P, Bakdach S et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin. Electrophysiol. 17(11 Pt 2), 1974–1979 (1994).
  • Leclercq C, Cazeau S, Le Breton H et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end stage heart failure. J. Am. Coll. Cardiol. 32(7), 1825–1831 (1994).
  • Auricchio A, Salo RW. Acute hemodynamic improvement by pacing in patients with severe congestive heart failure. Pacing Clin. Electrophysiol. 20(2 Pt 1), 313–324 (1997).
  • Auricchio A, Stellbrink C, Block M et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 99(23), 2993–3001 (1999).
  • Kass DA, Chen CH, Curry C et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 99(12), 1567–1573 (1999).
  • Saxon LA, Kerwin WF, Cahalan MK et al. Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function. J. Cardiovasc. Electrophysiol. 9(1), 13–21 (1998).
  • Nelson GS, Berger RD, Fetics BJ et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 102(25), 3053–3059 (2000).
  • Breithardt OA, Sinha AM, Schwammenthal E et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J. Am. Coll. Cardiol. 41(5), 765–770 (2003).
  • Gras D, Leclercq C, Tang AS, Bucknall C, Luttikhuis HO, Kirstein-Pedersen A. Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. Eur. J. Heart Fail. 4(3), 311–320 (2002).
  • Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med. 344(12), 873–880 (2001).
  • Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med. 346(24), 1845–1853 (2002).
  • Auricchio A, Stellbrink C, Sack S et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J. Am. Coll. Cardiol. 39(12), 2026–2033 (2001).
  • Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350(21), 2140–2150 (2004).
  • Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 352(15), 1539–1549 (2005).
  • Linde C, Leclercq C, Rex S et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J. Am. Coll. Cardiol. 40(1), 111–118 (2004).
  • StJohnSutton M, Plappert T, Abraham WT. Cardiac resynchronisation therapy results in left ventricular reverse remodelling: evidence from the MIRACLE study group. Circulation 104(Suppl. II), 2918 (2001).
  • Young JB, Abraham WT, Smith AL et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289(20), 2685–2694 (2003).
  • Thackray S, Coletta A, Jones P, Dunn A, Clark AL, Cleland JG. Clinical trials update: highlights of the scientific sessions of heart failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF. Eur. J. Heart Fail. 3(4), 491–494 (2001).
  • Saxon LA, Boehmer JP, Hummel J et al. Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. Am. J. Cardiol. 83(5B), 120D–123D (1999).
  • Louis A, Cleland JG, Crabbe S et al. Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001. Eur. J. Heart Fail. 3(3), 381–387 (2001).
  • Cleland JG, Daubert JC, Erdmann E et al. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study), rationale, design and end points. Eur. J. Heart Fail. 3(4), 481–489 (2001).
  • Bradley DJ, Bradley EA, Baughman KL et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 289(6), 730–740 (2003).
  • Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J. Am. Coll. Cardiol. 39(2), 194–201 (2002).
  • Hamdan MH, Zagrodzky JD, Joglar JA et al. Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation 102(9), 1027–1032 (2000).
  • Hamdan MH, Barbera S, Kowal RC et al. Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 89(9), 1047–1051 (2002).
  • Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 105(11), 1304–1310 (2002).
  • Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 108(3), 266–269 (2003).
  • Erol-Yilmaz A, Verberne HJ, Schrama TA et al. Cardiac resynchronization induces favorable neurohumoral changes. Pacing Clin. Electrophysiol. 28(4), 304–310 (2005).
  • Patel AD, Iskandrian AE. MIBG imaging. J. Nucl. Cardiol. 9(1), 75–94 (2002).
  • Merlet P, Benvenuti C, Moyse D et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J. Nucl. Med. 40(6), 917–923 (1999).
  • Conaway DG, Sullivan R, McCullough PA. Improved symptoms, physical limitation, and self-efficacy after resynchronization in a patient with heart failure and a prolonged QRS duration. Rev. Cardiovasc. Med. 5(1), 53–57 (2004).
  • Molhoek SG, Bax JJ, van Erven L et al. Atrial and brain natriuretic peptides as markers of response to resynchronisation therapy. Heart 90(1), 97–98 (2004).
  • Santos JF, Caetano F, Parreira L et al. Tissue Doppler echocardiography for evaluation of patients with ventricular resynchronization therapy. Rev. Port. Cardiol. 22(11), 1363–1371 (2003).
  • Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure. Ital. Heart J. 5(5), 364–370 (2004).
  • Ansalone G, Giannantoni P, Ricci R et al. Doppler myocardial imaging in patients with heart failure receiving biventricular pacing treatment. Am. Heart J. 142(5), 881–896 (2001).
  • Blanc JJ, Bertault-Valls V, Fatemi M, Gilard M, Pennec PY, Etienne Y. Midterm benefits of left univentricular pacing in patients with congestive heart failure. Circulation 109(14), 1741–1744 (2004).
  • Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 89(1), 54–60 (2003).
  • Kass DA. Predicting cardiac resynchronization response by QRS duration: the long and short of it. J. Am. Coll. Cardiol. 42(12), 2125–2127 (2003).
  • Bax JJ, Ansalone G, Breithardt OA et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J. Am. Coll. Cardiol. 44(1), 1–9 (2003).
  • Auricchio A, Yu CM. Beyond the measurement of QRS complex toward mechanical dyssynchrony: cardiac resynchronisation therapy in heart failure patients with a normal QRS duration. Heart 90(5), 479–481 (2004).
  • Penicka M, Bartunek J, De Bruyne B et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 109(8), 978–983 (2004).
  • Ansalone G, Giannantoni P, Ricci R, Trambaiolo P, Fedele F, Santini M. Biventricular pacing in heart failure: back to basics in the pathophysiology of left bundle branch block to reduce the number of nonresponders. Am. J. Cardiol. 91(9A), 55F–61F (2003).
  • Sogaard P, Egeblad H, Pedersen AK et al. Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation 106(16), 2078–2084 (2002).
  • Breithardt OA, Stellbrink C, Herbots L et al. Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block. J. Am. Coll. Cardiol. 42(3), 486–494 (2003).
  • Sun JP, Chinchoy E, Donal E et al. Evaluation of ventricular synchrony using novel Doppler echocardiographic indices in patients with heart failure receiving cardiac resynchronization therapy. J. Am. Soc. Echocardiogr. 17(8), 845–850 (2004).
  • Yu CM, Bleeker GB, Fung JW et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 112(11), 1580–1586 (2005).
  • Zwanenburg JJ, Gotte MJ, Kuijer JP, Heethaar RM, van Rossum AC, Marcus JT. Timing of cardiac contraction in humans mapped by high-temporal-resolution MRI tagging: early onset and late peak of shortening in lateral wall. Am. J. Physiol. Heart Circ. Physiol. 286(5), H1872–H1880 (2004).
  • Zwanenburg JJ, Gotte MJ, Kuijer JP et al. Regional timing of myocardial shortening is related to prestretch from atrial contraction: assessment by high temporal resolution MRI tagging in humans. Am. J. Physiol. Heart Circ. Physiol. 288(2), H787–H794 (2005).
  • Auricchio A, Klein H, Tockman B et al. Transvenous biventricular pacing for heart failure: can the obstacles be overcome? Am. J. Cardiol. 83(5B), 136D–142D (1999).
  • Yu CM, Abraham WT, Bax J et al. Predictors of response to cardiac resynchronization therapy (PROSPECT)-study design. Am. Heart J. 149(4), 600–605 (2005).
  • Gras D, Cebron JP, Brunel P, Leurent B, Banus Y. Optimal stimulation of the left ventricle. J. Cardiovasc. Electrophysiol. 13(1 Suppl.), S57–S62 (2002).
  • Puglisi A, Lunati M, Marullo AG et al. Limited thoracotomy as a second choice alternative to transvenous implant for cardiac resynchronisation therapy delivery. Eur. Heart J. 25(12), 1063–1069 (2004).
  • Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult-Summary Article. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J. Am. Coll. Cardiol. 46(6), 1116–1143 (2005).
  • Gregoratos G, Abrams J, Epstein AE et al. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and anti-arrhythmia devices – summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE, Committee to Update the 1998 Pacemaker Guidelines). J. Am. Coll. Cardiol. 40(9), 1703–1719 (2002).
  • Pitzalis MV, Iacoviello M, Romito R et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J. Am. Coll. Cardiol. 40(9), 1615–1622 (2002).
  • Pitzalis MV, Iacoviello M, Romito R et al. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. J. Am. Coll. Cardiol. 45(1), 65–69 (2005).
  • Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med. 346(24), 1845–1853 (2002).
  • Cazeau S, Bordachar P, Jauvert G et al. Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study. Pacing Clin. Electrophysiol. 26(1p2), 137–143 (2003).
  • Bax JJ, Marwick TH, Molhoek SG et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end stage heart failure before pacemaker implantation. Am. J. Cardiol. 92(10), 1238–1240 (2003).
  • Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of left ventricular systolic and diastolic asynchrony in patients with heart failure and normal QRS duration. Heart 89(1), 54–60 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.